15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          CD161 is a C-type lectin-like receptor expressed on the majority of natural killer (NK) cells; however, the significance of CD161 expression on NK cells has not been comprehensively investigated. Recently, we found that CD161 expression identifies a transcriptional and innate functional phenotype that is shared across various T cell populations. Using mass cytometry and microarray experiments, we demonstrate that this functional phenotype extends to NK cells. CD161 marks NK cells that have retained the ability to respond to innate cytokines during their differentiation, and is lost upon cytomegalovirus-induced maturation in both healthy and human immunodeficiency virus (HIV)-infected patients. These pro-inflammatory NK cells are present in the inflamed lamina propria where they are enriched for integrin CD103 expression. Thus, CD161 expression identifies NK cells that may contribute to inflammatory disease pathogenesis and correlates with an innate responsiveness to cytokines in both T and NK cells.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.

          The mechanisms underlying human natural killer (NK) cell phenotypic and functional heterogeneity are unknown. Here, we describe the emergence of diverse subsets of human NK cells selectively lacking expression of signaling proteins after human cytomegalovirus (HCMV) infection. The absence of B and myeloid cell-related signaling protein expression in these NK cell subsets correlated with promoter DNA hypermethylation. Genome-wide DNA methylation patterns were strikingly similar between HCMV-associated adaptive NK cells and cytotoxic effector T cells but differed from those of canonical NK cells. Functional interrogation demonstrated altered cytokine responsiveness in adaptive NK cells that was linked to reduced expression of the transcription factor PLZF. Furthermore, subsets of adaptive NK cells demonstrated significantly reduced functional responses to activated autologous T cells. The present results uncover a spectrum of epigenetically unique adaptive NK cell subsets that diversify in response to viral infection and have distinct functional capabilities compared to canonical NK cell subsets.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education.

            Natural killer (NK) cells are lymphocytes of the innate immune system that, following differentiation from CD56(bright) to CD56(dim) cells, have been thought to retain fixed functional and phenotypic properties throughout their lifespan. In contrast to this notion, we here show that CD56(dim) NK cells continue to differentiate. During this process, they lose expression of NKG2A, sequentially acquire inhibitory killer cell inhibitory immunoglobulin-like receptors and CD57, change their expression patterns of homing molecules, and display a gradual decline in proliferative capacity. All cellular intermediates of this process are represented in varying proportions at steady state and appear, over time, during the reconstitution of the immune system, as demonstrated in humanized mice and in patients undergoing hematopoietic stem cell transplantation. CD56(dim) NK-cell differentiation, and the associated functional imprint, occurs independently of NK-cell education by interactions with self-human leukocyte antigen class I ligands and is an essential part of the formation of human NK-cell repertoires.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.

              Natural killer (NK) cells are innate immune lymphocytes that express a heterogeneous repertoire of germline-encoded receptors and undergo a distinct pattern of maturation. CD57 is a marker of terminal differentiation on human CD8(+) T cells. Very few newborn or fetal NK cells express CD57; however, the frequency of CD57-bearing NK cells increases with age. We assessed the transcriptional, phenotypic, and functional differences between CD57(+) and CD57(-) NK cells within the CD56(dim) mature NK subset. CD57(+) NK cells express a repertoire of NK-cell receptors, suggestive of a more mature phenotype, and proliferate less when stimulated with target cells and/or cytokines. By contrast, a higher frequency of CD57(+) NK cells produced interferon-γ and demonstrated more potent lytic activity when these cells were stimulated through the activating receptor CD16; however, they are less responsive to stimulation by interleukin-12 and interleukin-18. Finally, CD57 expression is induced on CD57(-)CD56(dim) NK cells after activation by interleukin-2. A combination of a mature phenotype, a higher cytotoxic capacity, a higher sensitivity to stimulation via CD16, with a decreased responsiveness to cytokines, and a decreased capacity to proliferate suggest that CD57(+) NK cells are highly mature and might be terminally differentiated.
                Bookmark

                Author and article information

                Contributors
                URI : https://frontiersin.org/people/u/379083
                URI : https://frontiersin.org/people/u/478605
                URI : https://frontiersin.org/people/u/466442
                URI : https://frontiersin.org/people/u/340767
                URI : https://frontiersin.org/people/u/306834
                URI : https://frontiersin.org/people/u/499465
                URI : https://frontiersin.org/people/u/58862
                URI : https://frontiersin.org/people/u/203277
                URI : https://frontiersin.org/people/u/414572
                URI : https://frontiersin.org/people/u/103539
                URI : https://frontiersin.org/people/u/59888
                URI : https://frontiersin.org/people/u/24218
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                09 April 2018
                2018
                : 9
                : 486
                Affiliations
                [1] 1The Peter Medawar Building for Pathogen Research, University of Oxford , Oxford, United Kingdom
                [2] 2Ragon Institute of Massachusetts General Hospital, Harvard University, Massachusetts Institute of Technology , Cambridge, MA, United States
                [3] 3Agency for Science, Technology and Research (A*STAR), Singapore Immunology Network (SIgN) , Singapore, Singapore
                [4] 4Translational Gastroenterology Unit, Experimental Medicine Division, University of Oxford, John Radcliffe Hospital , Oxford, United Kingdom
                [5] 5Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University , Stockholm, Sweden
                [6] 6Division of Infectious Diseases, University Hospital Berne, University of Berne , Berne, Switzerland
                [7] 7Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich , Zurich, Switzerland
                [8] 8Institute of Medical Virology, University of Zurich , Zurich, Switzerland
                [9] 9Division of Infectious Diseases, University Hospital Basel , Basel, Switzerland
                [10] 10Institute of Cellular Medicine, Newcastle University , Newcastle upon Tyne, United Kingdom
                [11] 11NIHR Biomedical Research Centre, University of Oxford , Oxford, United Kingdom
                Author notes

                Edited by: Eleanor Riley, University of Edinburgh, United Kingdom

                Reviewed by: Martin R. Goodier, London School of Hygiene & Tropical Medicine, United Kingdom; Sophie Caillat-Zucman, Institut National de la Santé et de la Recherche Médicale (INSERM), France; Bree Foley, Telethon Kids Institute, Australia

                *Correspondence: Ayako Kurioka, ayako.kurioka@ 123456ndm.ox.ac.uk

                Specialty section: This article was submitted to NK and Innate Lymphoid Cell Biology, a section of the journal Frontiers in Immunology

                Article
                10.3389/fimmu.2018.00486
                5900032
                29686665
                62fd1689-f6da-462c-9924-4fce90f76f0b
                Copyright © 2018 Kurioka, Cosgrove, Simoni, van Wilgenburg, Geremia, Björkander, Sverremark-Ekström, Thurnheer, Günthard, Khanna, The Swiss HIV Cohort Study, Oxford IBD Cohort Investigators, Walker, Arancibia-Cárcamo, Newell, Willberg and Klenerman.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 19 September 2017
                : 23 February 2018
                Page count
                Figures: 5, Tables: 0, Equations: 0, References: 61, Pages: 14, Words: 9506
                Funding
                Funded by: Wellcome Trust 10.13039/100004440
                Award ID: WT091663MA
                Funded by: National Institutes of Health 10.13039/100000002
                Award ID: U19AI082630
                Funded by: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 10.13039/501100001711
                Award ID: 33CS30_148522
                Categories
                Immunology
                Original Research

                Immunology
                natural killer cells,cd161,pro-inflammatory cytokines,cytomegalovirus,human immunodeficiency virus,inflammatory bowel diseases

                Comments

                Comment on this article